The top after-market NASDAQ stock market losers are: RINO International, Renasant, Anadigics, China Natural Gas, Allos Therapeutics, Sina, Avanir Pharmaceuticals, Mattel, Ariad Pharmaceuticals, and Bob Evans Farms.

RINO International Corp. (RINO) lost 10.63 percent to $6.39 in the after-market trading. Law firms Roy Jacobs & Associates, Rosen Law Firm, Glancy Binkow & Goldberg LLP, and Faruqi & Faruqi LLP are investigating possible violations of laws as certain statements regarding the company's business, operations and prospects misrepresented RINO's financial performance.

RINO reported a 48.3 percent fall in third quarter profit that came in below analysts expectations. The company lowered its full year 2010 revenue guidance, lower than analysts forecast, due to weaker than expected third quarter and disruption caused by industry consolidation.

Renasant Corp. (RNST) plunged 6.65 percent to $16.29 in the after-hours session.

Anadigics, Inc. (ANAD) plummeted 5.35 percent to $5.13 in the after-market trading.

China Natural Gas, Inc. (CHNG) fell 5.23 percent to $4.71 in the after-hours session.

Allos Therapeutics, Inc. (ALTH) dropped 4.39 percent to $4.14 in the after-market trading.

Sina Corp. (SINA) tumbled 3.97 percent to $54.73 in the after-hours session. The company's third quarter adjusted profit was $31.3 million or 50 cents a share, up from $20.1 million or 34 cents a share last year. Adjusted revenue rose 20 percent to $103.6 million. Analysts expected profit of 43 cents a share on revenue of $103.21 million. Sina expects fourth quarter adjusted revenue of $103 million to $106 million, lower than analysts forecast of $108.65 million.

Avanir Pharmaceuticals (AVNR) declined 3.46 percent to $4.46 in the after-market trading. The company said it plans to sell shares of its common stock in an underwritten public offering.

Mattel Inc. (MAT) decreased 3.16 percent to $23.56 in the after-hours session. Billionaire Carl Icahn acquired stakes in Mattel and Masco Corp. (MAS) and sold the remainder of his shares in Yahoo! Inc. (YHOO) in the third quarter, a regulatory filing showed on Monday.

Ariad Pharmaceuticals Inc. (ARIA) moved down 1.94 percent to $3.54 in the after-market trading.

Bob Evans Farms Inc. (BOBE) fell 1.44 percent to $29.39 in the after-hours session. The company's second quarter profit was $7.8 million or 26 cents a share, down from $15.5 million or 50 cents a share last year. Sales declined 1.8 percent to $417.0 million. Analysts had expected profit of 40 cents a share on revenue of $421.25 million.

Bob Evans Farms still expects fiscal 2011 sales of about $1.7 billion, while analysts forecast $1.68 billion. The company's board authorized a share repurchase program of up to $25 million during fiscal 2011.